Fundz

Transition Bio reported raising $13.3 Million in an initial SEC Form D filing, from an offering of $21.3 Million

PRIVATEOct 25, 2024$13.3M of $21.3M raised

Amount Raised

$13.3 Million

$13.3 Million per company press release (Oct 30, 2024)

Round Type

Venture

CambridgeBiotechnologyBiotechnology Research

Investors

San Magnetic VenturesTaiho VenturesLifeforce CapitalBristol Myers SquibbNorthpond Ventures

Quick answer

Transition Bio raised $13.3 Million in a funding round, dated October 11, 2024. Investors: San Magnetic Ventures, Taiho Ventures, Lifeforce Capital, Bristol Myers Squibb and Northpond Ventures. Transition Bio is based in Cambridge, Massachusetts, United States.

How much did Transition Bio raise?
Transition Bio raised $13.3 Million in a funding round on October 11, 2024.
Who invested in Transition Bio?
San Magnetic Ventures, Taiho Ventures, Lifeforce Capital, Bristol Myers Squibb and Northpond Ventures are named as investors in this round.
What does Transition Bio do?
Transition Bio is developing one-of-a-kind technologies for biomolecular condensate analysis.
Where is Transition Bio based and how big is it?
Transition Bio is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Transition Bio?
Fundz holds 1 contact at Transition Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology Research and Biotechnology around the same time

Companies in the same sectors as Transition Bio that raised within 45 days of this round, from Fundz verified event records.

  • Prelude raised $8.1M (Seed) on November 13, 2024.
  • Neoplas Med GmbH raised $18M (Funding Round) on November 25, 2024.
  • Ukhi raised $1.2M (Pre-Seed) on November 25, 2024.
  • Adcendo raised $135M (Series B) on November 25, 2024.
  • Laennec AI Limited raised an undisclosed amount (Pre-Seed) on November 25, 2024.
  • LabVoice raised $700K (Seed) on November 24, 2024.

Who to call at Transition Bio, and when

A new round usually means Transition Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Transition Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Transition Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Transition Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Transition Bio

Location

Cambridge, Massachusetts, United States

About

Transition Bio is developing one-of-a-kind technologies for biomolecular condensate analysis. Through our Condensomics platform, our goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. We harness droplet microfluidic approaches and cellular platforms to characterize condensates with unprecedented scale and precision, resulting in the mapping of condensates and their modulation, in molecular detail. Our proprietary datasets feed in to algorithms that we use for target discovery, target validation and drug design.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Transition Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts8 people are listed at Transition Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Transition Bio's next move

See what Strategic adds

Transition Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.